Le Lézard
Classified in: Health
Subject: MAT

Five RMA of Connecticut Fertility Specialists Receive Top Doc Honors From Castle Connolly's America's Top Doctors® for 2020


NORWALK, Conn., Jan. 8, 2020 /PRNewswire-PRWeb/ -- RMA of Connecticut, a leading fertility practice whose exceptional quality and care helps couples and individuals grow their family, has announced that five of their Board-Certified reproductive endocrinologists have been honored with the prestigious Top Doc award by Castle Connolly. Since 1991, the renowned publishing company Castle Connolly has compiled the list of America's Top Doctors® each year. Every doctor on the list is nominated by peer doctors in their specific field and assessed by a physician-led research team.

The Top Doc designation was awarded to:
Mark Leondires, MD
Spencer Richlin, MD
Joshua Hurwitz, MD
Cynthia Murdock, MD
Shaun Williams, MD

Top Docs are rigorously selected from among the total population of 700,100 physicians (including the 1,269 board-certified reproductive endocrinologists) in practice in the United States. Castle Connolly's research methodology is designed to identify doctors who will achieve the best possible health outcomes. For a reproductive endocrinologist, that translates to successful fertility treatment cycles (IUI and IVF), resulting in pregnancies and babies. All six RMA of Connecticut physicians, including Ilana Ressler, MD, who is new to the practice, are at the top of their field and have the most up-to-date knowledge and skills in the field of Reproductive Endocrinology, the medical specialty dedicated to fertility treatment.

"We are proud to receive Top Doc honors for several consecutive years now," says Robin Mangieri, CEO, RMA of Connecticut. "This recognition is a testament to all of our physician's hard work and passion for what they do, as well as the lives they impact. Our practice was built to envelop our patients in 360-degree patient care, and this distinction, as voted on by their physician-peers, provides us with a sense of affirmation of this goal."

Learn more about the Top Doc designation as well as how to choose a fertility doctor in our free downloadable guide.

About Reproductive Medicine Associates of Connecticut (RMA of Connecticut)
RMA of Connecticut is a leader in fertility care, specializing in a range of infertility treatments. Our assisted reproductive technologies (ART) include intrauterine insemination (IUI), in-vitro fertilization (IVF) and pre-implantation genetic testing (PGT). RMA of Connecticut is Fairfield County's largest fertility clinic and egg donation center. Through RMA of Connecticut's Integrated Fertility and Wellness Center, we offer nutrition counseling, individual and couples psychological counseling, acupuncture and yoga, as well as financing and support services for our patients going through infertility treatment.

Our internationally recognized Gay Parents To Be® program at RMA of Connecticut specializes in LGBTQ family building. In 2017, 2018, and 2019, RMA of Connecticut was recognized as a Leader in Healthcare Equality by the Human Rights Campaign.

The RMA of Connecticut team includes lead physicians Drs. Mark P. Leondires, Spencer S. Richlin, Joshua M. Hurwitz, Cynthia M. Murdock, Shaun C. Williams, as well as fertility specialist, Dr. Ilana B. Ressler. All six physicians are Board-Certified Reproductive Endocrinologists and are members of the American Society for Reproductive Medicine (ASRM). Our team of doctors are named as Castle Connolly "Top Doctors" and are members of the Society for Assisted Reproductive Technology (SART). RMA of Connecticut's IVF laboratory is accredited by the College of American Pathologists (CAP), and CLIA. Other accreditations include the Accreditation Association for Ambulatory Health Care (AAAHC). RMA of Connecticut has offices in Danbury, Norwalk, Stamford, Trumbull and Poughkeepsie, New York.

For more information visit https://www.RMACT.com or find us on Facebook.

 

SOURCE Reproductive Medicine Associates of Connecticut


These press releases may also interest you

at 01:00
PrecisionLife has confirmed it is extending its relationships with some of the largest COVID-19 collaborative research projects and is now offering free use of its unique analytics platform and support from its data and biomedical science teams to...

at 01:00
UK biotech Imophoron has produced multiple COVID-19 vaccine candidates, based on its novel vaccine platform (named the ADDomer©), within weeks of the virus sequence being made available....

at 01:00
We're all affected by the current COVID-19 crisis and we understand that preclinical and clinical research may be slowing down. InstantGMP, Inc. wants to help by awarding COVID-19 Stimulus Grants that can help biotech companies keep up with their...

at 00:00
COMPLIANCY GROUP in its ongoing efforts to educate HIPAA covered entities, business associates, and managed service providers, has developed several resources to provide guidance on working from home. With the COVID-19 outbreak, most businesses have...

at 00:00
FDA's Regulation of Digital Health Wearables & Sensors An FDAnews Webinar Tuesday, April 21, 2020 ? 1:30-3:00 p.m. EDT https://www.fdanews.com/wearablesandsensors The digital health wearable and sensors market is rapidly growing. What is one's...

6 avr 2020
Emerald Health Therapeutics, Inc. ("Emerald") announces that it intends to amend the terms of certain common share purchase warrants originally issued on September 9, 2019 (the "Warrants"). An aggregate of 12,500,000 Warrants were initially issued...



News published on 8 january 2020 at 09:00 and distributed by: